SCHEMBL7364423

SCHEMBL7364423

O=C(CCCCCCC(=O)C(F)(F)F)Nc1cccc(OC(F)(F)F)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 10/20 0.78
HDAC2 Q92769 9/20 0.78
HDAC3 O15379 8/20 0.78
HDAC10 Q969S8 7/20 0.78
HDAC11 Q96DB2 7/20 0.78
HDAC8 Q9BY41 7/20 0.78
HDAC6 Q9UBN7 7/20 0.78
HDAC4 P56524 6/20 0.78
HDAC7 Q8WUI4 6/20 0.78
HDAC9 Q9UKV0 6/20 0.78
HDAC5 Q9UQL6 6/20 0.78
NCOR1 O75376 1/20 0.67
PRMT5 O14744 1/20 0.54
WDR77 Q9BQA1 1/20 0.54
NCOR2 Q9Y618 1/20 0.53
ALDH1A1 P00352 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371566 0.89 HDAC3 (0.76) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL7375595 0.88 HDAC1 (1.00) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL26623397 0.87 HDAC3 (0.60) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL7368436 0.87 HDAC1 (0.78) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL23060408 0.86 F2R (0.59) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL7365012 0.83 HDAC1 (0.76) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL9842887 0.83 F2R (0.68) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL7372007 0.82 HDAC1 (0.70) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL7371465 0.82 HDAC3 (0.71) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL2702892 0.81 HDAC4 (1.00) HDAC1HDAC2HDAC3HDAC10HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US claimed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 HDAC1 1/4885HDAC2 7/4885HDAC3 6/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.